Soleno Therapeutics (SLNO) Shares Issued (2014 - 2025)
Soleno Therapeutics (SLNO) reported Shares Issued of -$198.5 million for Q4 2025, down 34.46% year-over-year from -$302.9 million in Q4 2024, and down 194.29% on a QoQ basis from $210.5 million in Q3 2025.
Soleno Therapeutics (SLNO) has 8 years of Shares Issued data on file, last reported at -$198.5 million in Q4 2025.
- Quarterly Shares Issued fell 34.46% year-over-year to -$198.5 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $14.2 million (up 316.89% YoY) and the FY2025 annual result came in at $17.2 million, up 1207.14% from the prior year.
- Shares Issued fell to -$198.5 million in Q4 2025 per SLNO's latest filing, from $210.5 million in the prior quarter.
- Across five years, Shares Issued topped out at $210.5 million in Q3 2025 and bottomed at -$198.5 million in Q4 2025.
- The 3-year median for Shares Issued is $1.5 million (2024), against an average of $2.7 million.
- Peak annual rise in Shares Issued reached 1666.7% in 2024, while the deepest fall reached 42647.26% in 2024.
- Tracing SLNO's Shares Issued over 3 years: stood at $347000.0 in 2023, then plunged by 42647.26% to -$147.6 million in 2024, then slumped by 34.46% to -$198.5 million in 2025.
- Per Business Quant, the three latest SLNO Shares Issued figures stand at -$198.5 million (Q4 2025), $210.5 million (Q3 2025), and $2.2 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -198.52 Mn |
| Dec 31, 2025 | -198.52 Mn |
| Sep 30, 2025 | 210.53 Mn |
| Sep 30, 2025 | 210.53 Mn |
| Jun 30, 2025 | 2.18 Mn |
| Jun 30, 2025 | 2.18 Mn |
| Mar 31, 2025 | 3.01 Mn |
| Mar 31, 2025 | 3.01 Mn |
| Dec 31, 2024 | -147.64 Mn |
| Dec 31, 2024 | -147.64 Mn |
| Sep 30, 2024 | 148.40 Mn |
| Sep 30, 2024 | 148.40 Mn |
| Jun 30, 2024 | -371,000.00 |
| Jun 30, 2024 | -371,000.00 |
| Mar 31, 2024 | 923,000.00 |
| Mar 31, 2024 | 923,000.00 |
| Dec 31, 2023 | 347,000.00 |
| Dec 31, 2023 | 347,000.00 |
| Sep 30, 2023 | 8.40 Mn |
| Sep 30, 2023 | 8.40 Mn |
| Sep 30, 2020 | -53.93 Mn |
| Sep 30, 2020 | -53.93 Mn |
| Mar 31, 2017 | 10.00 Mn |
| Mar 31, 2017 | 10.00 Mn |
| Dec 31, 2016 | -70,000.00 |
| Dec 31, 2016 | -70,000.00 |
| Jun 30, 2016 | 70,000.00 |
| Jun 30, 2016 | 70,000.00 |
| Dec 31, 2015 | 1.14 Mn |
| Dec 31, 2015 | 1.14 Mn |
| Jun 30, 2015 | 282,000.00 |
| Jun 30, 2015 | 282,000.00 |
| Mar 31, 2015 | 12,000.00 |
| Mar 31, 2015 | 12,000.00 |
| Dec 31, 2014 | -2,000.00 |
| Dec 31, 2014 | -2,000.00 |